search

Active clinical trials for "Angina Pectoris"

Results 21-30 of 454

iCorMicA - Stratified Medicine in Angina

Microvascular AnginaAngina9 more

The iCorMicA study is a multicentre, prospective, randomised, double-blind, sham-controlled, parallel-group, end-point trial and registry. The investigators seek to determine whether stratified medical therapy guided by an adjunctive interventional diagnostic procedure (IDP) during the invasive management of patients with known or suspected angina but no obstructive coronary artery disease improves symptoms, wellbeing, cardiovascular risk and clinical outcomes.

Recruiting9 enrollment criteria

Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization...

Stable Angina PectorisCoronary Artery Disease1 more

The purpose of this study is to evaluate the efficacy and safety aspirin in patients with chronic coronary syndromes without revascularization.

Recruiting14 enrollment criteria

ReACHallenge Trial: Acetylcholine Rechallenge After Pretreatment With Vasoactive Drugs

Angina PectorisVariant2 more

The goal of this clinical trial is to assess the feasibility and clinical value of acetylcholine (ACH) rechallenge after intracoronary verapamil +- nitroglycerine in a patient cohort with angina and non-obstructive coronary arteries (ANOCA). The main questions it aims to answer are: to determine the efficacy of these drugs in treating ACH-induced coronary artery spasm to determine the efficacy of these drugs in preventing ACH-induced coronary artery spasm The ACH rechallenge will take place during the index coronary function tests in patients with proven ACH-induced vasospastic angina. The study is considered a feasibility study, no control arm is included.

Recruiting14 enrollment criteria

BVS Implantation in Patients With Variant Angina and MODerate Coronary Artery Disease

Angina PectorisVariant

The purpose of this study is to determine whether BVS(Bioresorbable Vascular Scaffold) implantation with optimal medical therapy can improve the outcome of patients with variant angina and moderate coronary artery disease.

Enrolling by invitation11 enrollment criteria

Effectiveness of ECP Therapy in Stable Angina Pectoris Patients

CounterpulsationAngina Pectoris

External Counterpulsation (ECP) is a non-invasive therapy using pressured cuff that is performed on patients with refractory stable angina pectoris to relieve symptoms and increase quality of life. In Indonesia, waiting time for getting coronary artery bypass grafting (CABG) procedure for revascularization treatment in stable angina pectoris patients is way longer than international recommendation which correlates with increase morbidity and mortality during the waiting time. Utilization of ECP for such patients who wait for CABG procedure is still unclear. The investigator aim to evaluate efficacy of addition of ECP compared with medical therapy alone for this population. The efficacy is evaluated using measurement from echocardiography result, treadmill test result, and clinical outcome. if applicable, examination of myocardial perfusion using nuclear examination will also be performed.

Recruiting31 enrollment criteria

A Trial Comparing the Effectiveness and Tolerability of Medications in Older Adults With Stable...

AnginaStable Ischemic Heart Disease

To establish the effectiveness and tolerability of standard of care anti-anginal treatment (beta-blocker and calcium channel blocker medications) in older adults with symptomatic Stable Ischemic Heart Disease (SIHD) and multiple chronic conditions (MCC).

Recruiting35 enrollment criteria

RecoveryPlus Telerehab Platform Pilot Study

Heart DiseasesAngina9 more

In this prospective, single-arm study, we will look at the initiation, participation, sustained engagement, and safety of 100 adult subjects (ages 45 years or older) with recent (within the past 60 days) clinician referral to CR who are offered CTR via the RecoveryPlus platform. We want to understand the effectiveness of the RecoveryPlus platform in engaging participants in CR while remaining a safe alternative for the delivery of evidence-based CR content. The primary hypothesis of this study is that the RecoveryPlus CTR platform and patient-facing mobile application provide a safe alternative to traditional in-person CR, and demonstrate a high rate of initiation, participation, and engagement in CR exercise programming than traditional modes of CR delivery, as documented in the literature. Current in-person and non-personalized CR programming lacks RecoveryPlus' convenient remote access, easy-to-use digital tools to support independent, autonomous exercise, and a platform to facilitate engagement and feedback between patients and EPs.

Recruiting22 enrollment criteria

Improving Cardiac Rehabilitation Outcomes Through Mobile Case Management (iCARE)

Acute Myocardial InfarctionAcute Coronary Syndrome3 more

The purpose of this research is to find out if doing cardiac rehab at home, or a mix of cardiac rehab at home and in the clinic, is as effective as coming in to the clinic for cardiac rehab.

Recruiting5 enrollment criteria

SORT OUT X - Combo Stent Versus ORSIRO Stent

Coronary Heart DiseaseAngina Pectoris1 more

The aim of the Danish Organisation for randomised trials with clinical outcome (SORT OUT) is to compare the safety and efficacy of the ComboTM stent and Orsiro™ stent in the treatment of unselected patients with ischemic heart disease, using registry detection of clinically driven events.

Active12 enrollment criteria

Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic...

Atrial FibrillationCoronary Artery Disease2 more

This study evaluates the efficacy and safety of Edoxaban with the combination of edoxaban and antiplatelet in patients with stable CAD (coronary artery stenosis ≥50% on medical treatment or revascularized stable CAD [≥ 12 months for acute coronary syndrome and ≥ 6 months after stable CAD]) and high-risk atrial fibrillation (CHA2DS2-VASc score ≥2).

Active21 enrollment criteria
1234...46

Need Help? Contact our team!


We'll reach out to this number within 24 hrs